These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18485495)

  • 1. Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664.
    Galvan V; Zhang J; Gorostiza OF; Banwait S; Huang W; Ataie M; Tang H; Bredesen DE
    Behav Brain Res; 2008 Aug; 191(2):246-55. PubMed ID: 18485495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience.
    Zhang J; Gorostiza OF; Tang H; Bredesen DE; Galvan V
    Behav Brain Res; 2010 Jan; 206(2):202-7. PubMed ID: 19751769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.
    Nguyen TV; Galvan V; Huang W; Banwait S; Tang H; Zhang J; Bredesen DE
    J Neurochem; 2008 Feb; 104(4):1065-80. PubMed ID: 17986220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.
    Galvan V; Gorostiza OF; Banwait S; Ataie M; Logvinova AV; Sitaraman S; Carlson E; Sagi SA; Chevallier N; Jin K; Greenberg DA; Bredesen DE
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7130-5. PubMed ID: 16641106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
    CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal cleavage of the amyloid-beta protein precursor at Asp664: a switch associated with Alzheimer's disease.
    Banwait S; Galvan V; Zhang J; Gorostiza OF; Ataie M; Huang W; Crippen D; Koo EH; Bredesen DE
    J Alzheimers Dis; 2008 Feb; 13(1):1-16. PubMed ID: 18334752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
    Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
    J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
    Havas D; Hutter-Paier B; Ubhi K; Rockenstein E; Crailsheim K; Masliah E; Windisch M
    J Alzheimers Dis; 2011; 25(2):231-43. PubMed ID: 21403389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid.
    Chen G; Chen KS; Kobayashi D; Barbour R; Motter R; Games D; Martin SJ; Morris RG
    J Neurosci; 2007 Mar; 27(10):2654-62. PubMed ID: 17344403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein.
    Harris JA; Devidze N; Halabisky B; Lo I; Thwin MT; Yu GQ; Bredesen DE; Masliah E; Mucke L
    J Neurosci; 2010 Jan; 30(1):372-81. PubMed ID: 20053918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein.
    Dodart JC; Meziane H; Mathis C; Bales KR; Paul SM; Ungerer A
    Behav Neurosci; 1999 Oct; 113(5):982-90. PubMed ID: 10571480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
    Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
    Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease.
    Hartman RE; Izumi Y; Bales KR; Paul SM; Wozniak DF; Holtzman DM
    J Neurosci; 2005 Jun; 25(26):6213-20. PubMed ID: 15987951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.